Skip to main content
Top
Published in: Digestive Diseases and Sciences 12/2006

01-12-2006 | Original Paper

The Complex Functions of Mast Cells in Chronic Human Liver Diseases

Authors: Barbara Franceschini, Giorgia Ceva-Grimaldi, Carlo Russo, Nicola Dioguardi, Fabio Grizzi

Published in: Digestive Diseases and Sciences | Issue 12/2006

Login to get access

Abstract

Mast cells (MCs) are multifunctional effector cells of the immune system. MCs were originally thought to be involved in IgE-associated immediate hypersensitivity and allergic disorders, but it is now known that they contain or elaborate an array of mediators with a multitude of effects on many other cells. A number of studies have found that MCs are involved in various liver diseases. Although still controversial, they seem to be involved in the liver’s fibrotic response to chronic inflammation and parasitic infection. Hepatic fibrosis is the most frequent liver response to toxic, infectious, or metabolic agents. During the establishment of this pathological condition, there is an increase in the components of the basement membrane that leads to continuous basement membrane-like structures being raised within Disse’s space and a decrease in the number of sinusoid endothelial fenestrae. This leads to a complex process called “sinusoidal capillarization.” At the cellular level, liver fibrogenesis is initiated by hepatocyte necrosis, which induces the recruitment of a large number of inflammatory cells, including MCs, which can be considered the primary effectors of the process changing sinusoidal endothelial cells into capillary-type endothelial cells. We review the roles played by MCs in hepatic chronic diseases and describe a biopsy section of hepatic tissue taken from a patient with chronic C virus-related hepatitis showing diffuse sinusoidal capillarization and a high density of MCs. This observation has led us to hypothesize a relationship between these highly specialized cells and sinusoidal capillarization.
Literature
1.
go back to reference Ehrlich P (1878) Beitrage zur theorie und praxis der histologischen farbung. Thesis. Leipzig University, Leipzig Ehrlich P (1878) Beitrage zur theorie und praxis der histologischen farbung. Thesis. Leipzig University, Leipzig
2.
go back to reference Schwartz LB (1985) The mast cells. In: Kaplan AP (ed). Allergy, vol I. Churchill Livingstone, Edinburgh, pp 53–92 Schwartz LB (1985) The mast cells. In: Kaplan AP (ed). Allergy, vol I. Churchill Livingstone, Edinburgh, pp 53–92
3.
go back to reference Galli SJ (1990) New insights into “the riddle of the mast cells”: microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 62:5–33PubMed Galli SJ (1990) New insights into “the riddle of the mast cells”: microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 62:5–33PubMed
4.
go back to reference Burnet FM (1977) The probable relationship of some or all mast cells to the T-cell system. Cell Immunol 30:358–360CrossRefPubMed Burnet FM (1977) The probable relationship of some or all mast cells to the T-cell system. Cell Immunol 30:358–360CrossRefPubMed
5.
go back to reference Zucker-Franklin D, Grusky G, Hirayama N, Schnipper E (1981) The presence of mast cell precursors in rat peripheral blood. Blood 58:544–551PubMed Zucker-Franklin D, Grusky G, Hirayama N, Schnipper E (1981) The presence of mast cell precursors in rat peripheral blood. Blood 58:544–551PubMed
6.
go back to reference Welle M (1997) Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J Leukoc Biol 61:233–245PubMed Welle M (1997) Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J Leukoc Biol 61:233–245PubMed
7.
go back to reference Hatanaka K, Kitamura Y, Nishimune Y (1979) Local development of mast cells from bone marrow-derived precursors in the skin of mice. Blood 53:142–147PubMed Hatanaka K, Kitamura Y, Nishimune Y (1979) Local development of mast cells from bone marrow-derived precursors in the skin of mice. Blood 53:142–147PubMed
8.
go back to reference Hayashi C, Sonoda T, Nakano T, Nakayama H, Kitamura Y (1985) Mast-cell precursors in the skin of mouse embryos and their deficiency in embryos of Sl/Sld genotype. Dev Biol 109:234–241CrossRefPubMed Hayashi C, Sonoda T, Nakano T, Nakayama H, Kitamura Y (1985) Mast-cell precursors in the skin of mouse embryos and their deficiency in embryos of Sl/Sld genotype. Dev Biol 109:234–241CrossRefPubMed
9.
10.
go back to reference Krishnaswamy G, Kelley J, Johnson D, Youngberg G, Stone W, Huang SK, Bieber J, Chi DS (2001) The human mast cell: functions in physiology and disease. Front Biosci 6:D1109–D1127PubMed Krishnaswamy G, Kelley J, Johnson D, Youngberg G, Stone W, Huang SK, Bieber J, Chi DS (2001) The human mast cell: functions in physiology and disease. Front Biosci 6:D1109–D1127PubMed
11.
go back to reference Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M (2005) Mast cells as “tunable” effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23:749–286CrossRefPubMed Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M (2005) Mast cells as “tunable” effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23:749–286CrossRefPubMed
12.
go back to reference Strobel S, Miller HR, Ferguson A (1981) Human intestinal mucosal mast cells: evaluation of fixation and staining techniques. J Clin Pathol 34:851–858PubMed Strobel S, Miller HR, Ferguson A (1981) Human intestinal mucosal mast cells: evaluation of fixation and staining techniques. J Clin Pathol 34:851–858PubMed
14.
go back to reference Marone G, Lichtenstein LM, Galli SJ (2000) Mast cells and basophils. Academic Press, New York Marone G, Lichtenstein LM, Galli SJ (2000) Mast cells and basophils. Academic Press, New York
15.
go back to reference Castells MC, Irani AM, Schwartz LB (1987) Evaluation of human peripheral blood leukocytes for mast cell tryptase. J Immunol 138:2184–2189PubMed Castells MC, Irani AM, Schwartz LB (1987) Evaluation of human peripheral blood leukocytes for mast cell tryptase. J Immunol 138:2184–2189PubMed
16.
go back to reference Weidner N, Austen KF (1993) Heterogeneity of mast cells at multiple body sites. Fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase, and carboxypeptidase content. Pathol Res Pract 189:156–162PubMed Weidner N, Austen KF (1993) Heterogeneity of mast cells at multiple body sites. Fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase, and carboxypeptidase content. Pathol Res Pract 189:156–162PubMed
18.
go back to reference Kruger-Krasagakes S, Czarnetzki BM (1995) Cytokine secretion by human mast cells. Exp Dermatol 4:250–254CrossRefPubMed Kruger-Krasagakes S, Czarnetzki BM (1995) Cytokine secretion by human mast cells. Exp Dermatol 4:250–254CrossRefPubMed
19.
go back to reference Gruber BL (2003) Mast cells in the pathogenesis of fibrosis. Curr Rheumatol Rep 5:147–153PubMed Gruber BL (2003) Mast cells in the pathogenesis of fibrosis. Curr Rheumatol Rep 5:147–153PubMed
20.
go back to reference Kawakami T, Galli SJ (2002) Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2:773–786CrossRefPubMed Kawakami T, Galli SJ (2002) Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2:773–786CrossRefPubMed
21.
go back to reference Payne V, Kam PC (2004) Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia 59:695–703CrossRefPubMed Payne V, Kam PC (2004) Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia 59:695–703CrossRefPubMed
22.
go back to reference Mihm MC Jr, Soter NA, Dvorak HF, Austen KF (1976) The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 67:305–312CrossRefPubMed Mihm MC Jr, Soter NA, Dvorak HF, Austen KF (1976) The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 67:305–312CrossRefPubMed
23.
go back to reference Persinger MA, Lepage P, Simard JP, Parker GH (1983) Mast cell numbers in incisional wounds in rat skin as a function of distance, time and treatment. Br J Dermatol 108:179–187CrossRefPubMed Persinger MA, Lepage P, Simard JP, Parker GH (1983) Mast cell numbers in incisional wounds in rat skin as a function of distance, time and treatment. Br J Dermatol 108:179–187CrossRefPubMed
24.
go back to reference Grizzi F, Franceschini B, Chiriva-Internati M, Liu Y, Hermonat PL, Dioguardi N (2003) Mast cells and human hepatocellular carcinoma. World J Gastroenterol 9:1469–1473PubMed Grizzi F, Franceschini B, Chiriva-Internati M, Liu Y, Hermonat PL, Dioguardi N (2003) Mast cells and human hepatocellular carcinoma. World J Gastroenterol 9:1469–1473PubMed
25.
go back to reference Weiler-Norman C, Rehermann B (2004) The liver as an immunological organ. J Gastro Hepatol 19:5279–5283CrossRef Weiler-Norman C, Rehermann B (2004) The liver as an immunological organ. J Gastro Hepatol 19:5279–5283CrossRef
26.
go back to reference Murata K, Okudaira M, Akashio K (1973) Mast cells in human liver tissue. Increased mast cell number in relation to the components of connective tissue in the cirrhotic process. Acta Derm Venereol Suppl (Stockh) 73:157–165 Murata K, Okudaira M, Akashio K (1973) Mast cells in human liver tissue. Increased mast cell number in relation to the components of connective tissue in the cirrhotic process. Acta Derm Venereol Suppl (Stockh) 73:157–165
27.
go back to reference Hagmann W, Hacker HJ, Buchholz U (1992) Resident mast cells are the main initiators of anaphylactic leukotriene production in the liver. Hepatology 16:1477–1484PubMed Hagmann W, Hacker HJ, Buchholz U (1992) Resident mast cells are the main initiators of anaphylactic leukotriene production in the liver. Hepatology 16:1477–1484PubMed
29.
go back to reference Farrell DJ, Hines JE, Walls AF, Kelly PJ, Bennett MK, Burt AD (1995) Intrahepatic mast cells in chronic liver diseases. Hepatology 22:1175–1181CrossRefPubMed Farrell DJ, Hines JE, Walls AF, Kelly PJ, Bennett MK, Burt AD (1995) Intrahepatic mast cells in chronic liver diseases. Hepatology 22:1175–1181CrossRefPubMed
30.
go back to reference Armbrust T, Batusic D, Ringe B, Ramadori G (1997) Mast cell distribution in human liver disease and experimental rat liver fibrosis. Indications for mast cell participation in development of liver fibrosis. J Hepatol 26:1042–1054CrossRefPubMed Armbrust T, Batusic D, Ringe B, Ramadori G (1997) Mast cell distribution in human liver disease and experimental rat liver fibrosis. Indications for mast cell participation in development of liver fibrosis. J Hepatol 26:1042–1054CrossRefPubMed
31.
go back to reference Rioux KP, Sharkey KA, Wallace JL, Swain MG (1996) Hepatic mucosal mast cell hyperplasia in rats with secondary biliary cirrhosis. Hepatology 23:888–895CrossRefPubMed Rioux KP, Sharkey KA, Wallace JL, Swain MG (1996) Hepatic mucosal mast cell hyperplasia in rats with secondary biliary cirrhosis. Hepatology 23:888–895CrossRefPubMed
32.
go back to reference Gittlen SD, Schulman ES, Maddrey WC (1990) Raised histamine concentrations in chronic cholestatic liver disease. Gut 31:96–99PubMed Gittlen SD, Schulman ES, Maddrey WC (1990) Raised histamine concentrations in chronic cholestatic liver disease. Gut 31:96–99PubMed
33.
go back to reference Umezu K, Yuasa S, Ichikawa A (1986) Inhibitory mechanism of tritoqualine on histamine release from mast cells. Biochem Pharmacol 35:3137–3142CrossRefPubMed Umezu K, Yuasa S, Ichikawa A (1986) Inhibitory mechanism of tritoqualine on histamine release from mast cells. Biochem Pharmacol 35:3137–3142CrossRefPubMed
34.
go back to reference Peng RY, Wang DW, Xu ZH, Gao YB, Yang RB, Liu P, Wang ZP, Li YP (1994) The changes and significance of mast cells in irradiated rat liver. J Environ Pathol Toxicol Oncol 13:111–116PubMed Peng RY, Wang DW, Xu ZH, Gao YB, Yang RB, Liu P, Wang ZP, Li YP (1994) The changes and significance of mast cells in irradiated rat liver. J Environ Pathol Toxicol Oncol 13:111–116PubMed
35.
go back to reference Nakamura A, Yamazaki K, Suzuki K, Sato S (1997) Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis. Am J Gastroenterol 92:2245–2249PubMed Nakamura A, Yamazaki K, Suzuki K, Sato S (1997) Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis. Am J Gastroenterol 92:2245–2249PubMed
36.
go back to reference Okazaki T, Hirota S, Xu ZD, Maeyama K, Nakama A, Kawano S, Hori M, Kitamura Y (1998) Increase of mast cells in the liver and lung may be associated with but not a cause of fibrosis: demonstration using mast cell-deficient Ws/Ws rats. Lab Invest 78:1431–1438PubMed Okazaki T, Hirota S, Xu ZD, Maeyama K, Nakama A, Kawano S, Hori M, Kitamura Y (1998) Increase of mast cells in the liver and lung may be associated with but not a cause of fibrosis: demonstration using mast cell-deficient Ws/Ws rats. Lab Invest 78:1431–1438PubMed
37.
go back to reference Sugihara A, Tsujimura T, Fujita Y, Nakata Y, Terada N (1999) Evaluation of role of mast cells in the development of liver fibrosis using mast cell-deficient rats and mice. J Hepatol 30:859–867CrossRefPubMed Sugihara A, Tsujimura T, Fujita Y, Nakata Y, Terada N (1999) Evaluation of role of mast cells in the development of liver fibrosis using mast cell-deficient rats and mice. J Hepatol 30:859–867CrossRefPubMed
38.
go back to reference Satomura K, Shimizu S, Nagato T, Komeichi H, Osuga M, Katsuta Y, Aramaki T, Omoto Y (2002) Establishment of an assay method for human mast cell chymase. Hepatol Res 24:361–367CrossRefPubMed Satomura K, Shimizu S, Nagato T, Komeichi H, Osuga M, Katsuta Y, Aramaki T, Omoto Y (2002) Establishment of an assay method for human mast cell chymase. Hepatol Res 24:361–367CrossRefPubMed
39.
go back to reference Cairns JA, Walls AF (1997) Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest 99:1313–1321PubMed Cairns JA, Walls AF (1997) Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest 99:1313–1321PubMed
40.
go back to reference Gruber BL, Kew RR, Jelaska A, Marchese MJ, Garlick J, Ren S, Schwartz LB, Korn JH (1997) Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J Immunol 158:2310–2317PubMed Gruber BL, Kew RR, Jelaska A, Marchese MJ, Garlick J, Ren S, Schwartz LB, Korn JH (1997) Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J Immunol 158:2310–2317PubMed
41.
go back to reference Thompson HL, Burbelo PD, Gabriel G, Yamada Y, Metcalfe DD (1991) Murine mast cells synthesize basement membrane components. A potential role in early fibrosis. J Clin Invest 87:619–623 Thompson HL, Burbelo PD, Gabriel G, Yamada Y, Metcalfe DD (1991) Murine mast cells synthesize basement membrane components. A potential role in early fibrosis. J Clin Invest 87:619–623
42.
44.
go back to reference Gruber BL, Marchese MJ, Kew RR (1994) Transforming growth factor-beta 1 mediates mast cell chemotaxis. J Immunol 152:5860–5867PubMed Gruber BL, Marchese MJ, Kew RR (1994) Transforming growth factor-beta 1 mediates mast cell chemotaxis. J Immunol 152:5860–5867PubMed
45.
go back to reference Brito JM, Borojevic R (1997) Liver granulomas in schistosomiasis: mast cell-dependent induction of SCF expression in hepatic stellate cells is mediated by TNF-alpha. J Leukoc Biol 62:389–396PubMed Brito JM, Borojevic R (1997) Liver granulomas in schistosomiasis: mast cell-dependent induction of SCF expression in hepatic stellate cells is mediated by TNF-alpha. J Leukoc Biol 62:389–396PubMed
46.
go back to reference Terada T, Matsunaga Y (2000) Increased mast cells in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Hepatol 33:961–966CrossRefPubMed Terada T, Matsunaga Y (2000) Increased mast cells in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Hepatol 33:961–966CrossRefPubMed
47.
go back to reference Makhlouf HR, Ishak KG (2002) Sclerosed hemangioma and sclerosing cavernous hemangioma of the liver: a comparative clinicopathologic and immunohistochemical study with emphasis on the role of mast cells in their histogenesis. Liver 22:70–78CrossRefPubMed Makhlouf HR, Ishak KG (2002) Sclerosed hemangioma and sclerosing cavernous hemangioma of the liver: a comparative clinicopathologic and immunohistochemical study with emphasis on the role of mast cells in their histogenesis. Liver 22:70–78CrossRefPubMed
48.
go back to reference Tsuneyama K, Kono N, Yamashiro M, Kouda W, Sabit A, Sasaki M, Nakanuma Y (1999) Aberrant expression of stem cell factor on biliary epithelial cells and peribiliary infiltration of c-kit-expressing mast cells in hepatolithiasis and primary sclerosing cholangitis: a possible contribution to bile duct fibrosis. J Pathol 189:609–614CrossRefPubMed Tsuneyama K, Kono N, Yamashiro M, Kouda W, Sabit A, Sasaki M, Nakanuma Y (1999) Aberrant expression of stem cell factor on biliary epithelial cells and peribiliary infiltration of c-kit-expressing mast cells in hepatolithiasis and primary sclerosing cholangitis: a possible contribution to bile duct fibrosis. J Pathol 189:609–614CrossRefPubMed
49.
go back to reference Satomura K, Yin M, Shimizu S, Kato Y, Nagano T, Komeichi H, Ohsuga M, Katsuta Y, Aramaki T, Omoto Y (2003) Increased chymase in livers with autoimmune disease: colocalization with fibrosis. J Nippon Med Sch 70:490–495CrossRefPubMed Satomura K, Yin M, Shimizu S, Kato Y, Nagano T, Komeichi H, Ohsuga M, Katsuta Y, Aramaki T, Omoto Y (2003) Increased chymase in livers with autoimmune disease: colocalization with fibrosis. J Nippon Med Sch 70:490–495CrossRefPubMed
50.
go back to reference Ozaki S, Sato Y, Yasoshima M, Harada K, Nakanuma Y (2005) Diffuse expression of heparan sulfate proteoglycan and connective tissue growth factor in fibrous septa with many mast cells relate to unresolving hepatic fibrosis of congenital hepatic fibrosis. Liver Int 25:817–828CrossRefPubMed Ozaki S, Sato Y, Yasoshima M, Harada K, Nakanuma Y (2005) Diffuse expression of heparan sulfate proteoglycan and connective tissue growth factor in fibrous septa with many mast cells relate to unresolving hepatic fibrosis of congenital hepatic fibrosis. Liver Int 25:817–828CrossRefPubMed
51.
go back to reference O’Keeffe C, Baird AW, Nolan N, McCormick PA (2002) Mast cell hyperplasia in chronic rejection after liver transplantation. Liver Transpl 8:50–57CrossRefPubMed O’Keeffe C, Baird AW, Nolan N, McCormick PA (2002) Mast cell hyperplasia in chronic rejection after liver transplantation. Liver Transpl 8:50–57CrossRefPubMed
53.
go back to reference Neubauer K, Saile B, Ramadori G (2001) Liver fibrosis and altered matrix synthesis. Can J Gastroenterol 15:1871–1893 Neubauer K, Saile B, Ramadori G (2001) Liver fibrosis and altered matrix synthesis. Can J Gastroenterol 15:1871–1893
54.
go back to reference Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, Wu S, Lang R, Iredale JP (2005) Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 115:56–65CrossRefPubMed Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, Wu S, Lang R, Iredale JP (2005) Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 115:56–65CrossRefPubMed
55.
go back to reference Mori T, Okanoue T, Sawa Y, Hori N, Ohta M, Kagawa K (1993) Defenestration of the sinusoidal endothelial cell in a rat model of cirrhosis. Hepatology 17:891–897CrossRefPubMed Mori T, Okanoue T, Sawa Y, Hori N, Ohta M, Kagawa K (1993) Defenestration of the sinusoidal endothelial cell in a rat model of cirrhosis. Hepatology 17:891–897CrossRefPubMed
56.
go back to reference Neubauer K, Kruger M, Quondamatteo F, Knittel T, Saile B, Ramadori G (1999) Transforming growth factor-beta1 stimulates the synthesis of basement membrane proteins laminin, collagen type IV and entactin in rat liver sinusoidal endothelial cells. J Hepatol 31:692–702CrossRefPubMed Neubauer K, Kruger M, Quondamatteo F, Knittel T, Saile B, Ramadori G (1999) Transforming growth factor-beta1 stimulates the synthesis of basement membrane proteins laminin, collagen type IV and entactin in rat liver sinusoidal endothelial cells. J Hepatol 31:692–702CrossRefPubMed
57.
go back to reference Xu GF, Li PT, Wang XY, Jia X, Tian DL, Jiang LD, Yang JX (2004) Dynamic changes in the expression of matrix metalloproteinases and their inhibitors, TIMPs, during hepatic fibrosis induced by alcohol in rats. World J Gastroenterol 10:3621–3627PubMed Xu GF, Li PT, Wang XY, Jia X, Tian DL, Jiang LD, Yang JX (2004) Dynamic changes in the expression of matrix metalloproteinases and their inhibitors, TIMPs, during hepatic fibrosis induced by alcohol in rats. World J Gastroenterol 10:3621–3627PubMed
58.
go back to reference Xu GF, Wang XY, Ge GL, Li PT, Jia X, Tian DL, Jiang LD, Yang JX (2004) Dynamic changes of capillarization and peri-sinusoid fibrosis in alcoholic liver diseases. World J Gastroenterol 10:238–243PubMed Xu GF, Wang XY, Ge GL, Li PT, Jia X, Tian DL, Jiang LD, Yang JX (2004) Dynamic changes of capillarization and peri-sinusoid fibrosis in alcoholic liver diseases. World J Gastroenterol 10:238–243PubMed
59.
go back to reference Zimmermann A, Zhao D, Reichen J (1999) Myofibroblasts in the cirrhotic rat liver reflect hepatic remodeling and correlate with fibrosis and sinusoidal capillarization. J Hepatol 30:646–652CrossRefPubMed Zimmermann A, Zhao D, Reichen J (1999) Myofibroblasts in the cirrhotic rat liver reflect hepatic remodeling and correlate with fibrosis and sinusoidal capillarization. J Hepatol 30:646–652CrossRefPubMed
60.
go back to reference Grizzi F, Franceschini B, Barbieri B, Gagliano N, Arosio B, Chiriva-Internati M, Annoni G, Dioguardi N (2002) Mast cell density: a quantitative index of acute liver inflammation. Anal Quant Cytol Histol 24:63–69PubMed Grizzi F, Franceschini B, Barbieri B, Gagliano N, Arosio B, Chiriva-Internati M, Annoni G, Dioguardi N (2002) Mast cell density: a quantitative index of acute liver inflammation. Anal Quant Cytol Histol 24:63–69PubMed
61.
go back to reference Dioguardi N, Franceschini B, Aletti G, Russo C, Grizzi F (2003) Fractal dimension rectified meter for quantification of liver fibrosis and other irregular microscopic objects. Anal Quant Cytol Histol 25:312–320PubMed Dioguardi N, Franceschini B, Aletti G, Russo C, Grizzi F (2003) Fractal dimension rectified meter for quantification of liver fibrosis and other irregular microscopic objects. Anal Quant Cytol Histol 25:312–320PubMed
62.
go back to reference Grizzi F, Franceschini B, Gagliano N, Moscheni C, Annoni G, Vergani C, Hermonat PL, Chiriva-Internati M, Dioguardi N (2003) Mast cell density, hepatic stellate cell activation and TGF-beta1 transcripts in the aging Sprague-Dawley rat during early acute liver injury. Toxicol Pathol 31:173–178CrossRefPubMed Grizzi F, Franceschini B, Gagliano N, Moscheni C, Annoni G, Vergani C, Hermonat PL, Chiriva-Internati M, Dioguardi N (2003) Mast cell density, hepatic stellate cell activation and TGF-beta1 transcripts in the aging Sprague-Dawley rat during early acute liver injury. Toxicol Pathol 31:173–178CrossRefPubMed
63.
go back to reference Garovoy MR, Reddish MA, Rocklin RE (1983) Histamine-induced suppressor factor (HSF): inhibition of helper T cell generation and function. J Immunol 130:357–361PubMed Garovoy MR, Reddish MA, Rocklin RE (1983) Histamine-induced suppressor factor (HSF): inhibition of helper T cell generation and function. J Immunol 130:357–361PubMed
64.
65.
go back to reference Kendall JC, Li XH, Galli SJ, Gordon JR (1997) Promotion of mouse fibroblast proliferation by IgE-dependent activation of mouse mast cells: role for mast cell tumor necrosis factor-alpha and transforming growth factor-beta 1. J Allergy Clin Immunol 99:113–123PubMed Kendall JC, Li XH, Galli SJ, Gordon JR (1997) Promotion of mouse fibroblast proliferation by IgE-dependent activation of mouse mast cells: role for mast cell tumor necrosis factor-alpha and transforming growth factor-beta 1. J Allergy Clin Immunol 99:113–123PubMed
66.
go back to reference Grutzkau A, Kruger-Krasagakes S, Baumeister H, Schwarz C, Kogel H, Welker P, Lippert U, Henz BM, Moller A (1998) Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF. Mol Biol Cell 9:875–884PubMed Grutzkau A, Kruger-Krasagakes S, Baumeister H, Schwarz C, Kogel H, Welker P, Lippert U, Henz BM, Moller A (1998) Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF. Mol Biol Cell 9:875–884PubMed
67.
go back to reference Yamane A, Seetharam L, Yamaguchi S, Gotoh N, Takahashi T, Neufeld G, Shibuya M (1994) A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). Oncogene 9:2683–2690PubMed Yamane A, Seetharam L, Yamaguchi S, Gotoh N, Takahashi T, Neufeld G, Shibuya M (1994) A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). Oncogene 9:2683–2690PubMed
68.
go back to reference Shibuya M (1995) Role of VEGF-flt receptor system in normal and tumor angiogenesis. Adv Cancer Res 67:281–316PubMedCrossRef Shibuya M (1995) Role of VEGF-flt receptor system in normal and tumor angiogenesis. Adv Cancer Res 67:281–316PubMedCrossRef
69.
go back to reference Mochida S, Ishikawa K, Toshima K, Inao M, Ikeda H, Matsui A, Shibuya M, Fujiwara K (1998) The mechanisms of hepatic sinusoidal endothelial cell regeneration: a possible communication system associated with vascular endothelial growth factor in liver cells. J Gastroenterol Hepatol 13(Suppl):S1–S5PubMed Mochida S, Ishikawa K, Toshima K, Inao M, Ikeda H, Matsui A, Shibuya M, Fujiwara K (1998) The mechanisms of hepatic sinusoidal endothelial cell regeneration: a possible communication system associated with vascular endothelial growth factor in liver cells. J Gastroenterol Hepatol 13(Suppl):S1–S5PubMed
70.
go back to reference Theoharides TC, Conti P (2004) Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol 25:235–241CrossRefPubMed Theoharides TC, Conti P (2004) Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol 25:235–241CrossRefPubMed
71.
go back to reference Huang GW, Yang LY (2002) Metallothionein expression in hepatocellular carcinoma. World J Gastroenterol 8:650–653PubMed Huang GW, Yang LY (2002) Metallothionein expression in hepatocellular carcinoma. World J Gastroenterol 8:650–653PubMed
Metadata
Title
The Complex Functions of Mast Cells in Chronic Human Liver Diseases
Authors
Barbara Franceschini
Giorgia Ceva-Grimaldi
Carlo Russo
Nicola Dioguardi
Fabio Grizzi
Publication date
01-12-2006
Published in
Digestive Diseases and Sciences / Issue 12/2006
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9082-8

Other articles of this Issue 12/2006

Digestive Diseases and Sciences 12/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine